Plasmid-based controls to detect rpoB mutations in Mycobacterium tuberculosis by quantitative polymerase chain reaction-high-resolution melting

Carregando...
Imagem de Miniatura

Data

2013-02-01

Autores

Silva, Joas Lucas da
Leite, Gabriela Guimaraes Sousa
Bastos, Gisele Medeiros
Lucas, Beatriz Cacciacarro
Shinohara, Daniel Keniti
Takinami, Joice Sayuri
Miyata, Marcelo
Fajardo, Cristina Moreno
Luchessi, André Ducati
Leite, Clarice Queico Fujimura [UNESP]

Título da Revista

ISSN da Revista

Título de Volume

Editor

Instituto Oswaldo Cruz, Ministério da Saúde

Resumo

Quantitative polymerase chain reaction-high-resolution melting (qPCR-HRM) analysis was used to screen for mutations related to drug resistance in Mycobacterium tuberculosis. We detected the C526T and C531T mutations in the rifampicin resistance-determining region (RRDR) of the rpoB gene with qPCR-HRM using plasmid-based controls. A segment of the RRDR region from M. tuberculosis H37Rv and from strains carrying C531T or C526T mutations in the rpoB were cloned into pGEM-T vector and these vectors were used as controls in the qPCR-HRM analysis of 54 M. tuberculosis strains. The results were confirmed by DNA sequencing and showed that recombinant plasmids can replace genomic DNA as controls in the qPCR-HRM assay. Plasmids can be handled outside of biosafety level 3 facilities, reducing the risk of contamination and the cost of the assay. Plasmids have a high stability, are normally maintained in Escherichia coli and can be extracted in large amounts.

Descrição

Palavras-chave

drug resistance, rifampicin, Mycobacterium tuberculosis

Como citar

Memórias do Instituto Oswaldo Cruz. Instituto Oswaldo Cruz, Ministério da Saúde, v. 108, n. 1, p. 106-109, 2013.